You are here

Article Text

Article menu
Download PDFPDF
Online mutation report
P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome
  1. N A Garrison1,*‡,
  2. Z Yi1,2,‡,
  3. O Cohen-Barak1,
  4. M Huizing3,
  5. L M Hartnell4,
  6. W A Gahl3,
  7. M H Brilliant1,2
  1. 1Department of Pediatrics, College of Medicine, University of Arizona, Tucson, AZ 85724, USA
  2. 2Graduate Interdisciplinary Program in Genetics, University of Arizona, Tucson, AZ 85724, USA
  3. 3Section on Human Biochemical Genetics, Heritable Disorders Branch, National Institute of Child Health and Human Development, and Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD 20892, USA
  4. 4Cell Biology and Metabolism Branch, NICHD, NIH, Bethesda, MD 20892, USA
  1. Correspondence to:
 M H Brilliant
 Department of Pediatrics, PO Box 245073, University of Arizona College of Medicine, 1501 N. Campbell Avenue, Tucson, AZ 85724, USA; mhbpeds.arizona.edu

https://doi.org/10.1136/jmg.2003.014902

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Oculocutaneous albinism (OCA) is a genetically heterogeneous disorder characterised by abnormally low amounts of melanin in the eyes, skin, and hair. In addition to hypopigmentation of the skin and eyes, OCA patients have ocular manifestations including nystagmus, foveal hypoplasia with reduced visual acuity, and strabismus.1 Several subtypes of OCA exist. OCA2, the most common subtype, results from mutations in the P gene.2,3 OCA2 patients have a broad range of phenotypes, with minimal to moderate pigmentation of the hair, skin, and iris that may darken with age.1 OCA1 is the second most common type and is caused by mutations in the tyrosinase gene, TYR.4,5 The lack of functional tyrosinase results in the complete absence of pigmentation in hair and skin. Rarer forms of OCA include OCA3, also known as “rufous/red albinism” and associated with mutations in the TYRP1 gene,6 and OCA4, associated with mutations in the MATP gene.7 Finally, some genetic defects in intracellular vesicle formation and trafficking have OCA as a major clinical component.8,9 For example, Chediak-Higashi syndrome (CHS) is characterised by giant intracellular granules, an often fatal diathesis to infection, and variable degrees of hypopigmentation.10 Hermansky-Pudlak syndrome (HPS) involves OCA as part of a constellation of findings that include platelet storage pool deficiency and, in some patients, accumulation of ceroid pigment, pulmonary fibrosis, and/or granulomatous colitis.11 The sine qua non of HPS is absence of platelet dense bodies on whole mount electron microscopy.12 CHS and HPS can have overlapping phenotypes. For example, HPS-2, associated with mutations in the β3A subunit of adaptor complex-3,13 manifests with neutropenia and childhood infections reminiscent of CHS.14,15

    Because of our interest in hypopigmentation and disorders of intracellular vesicles, we investigated all patients having OCA plus a history …

    View Full Text

    Footnotes

    • This work was supported by National Institutes of Health grant AR4596 (to MHB). NAG was supported by MARC program Grant T34 GM08718.

    • Conflict of interest: none declared.

    • ↵* Current address: Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA

    • ↵‡ These authors contributed equally to this work.